Comparison of dispersive liquid–liquid microextraction based on organic solvent and ionic liquid combined with high‐performance liquid chromatography for the analysis of emodin and its metabolites in urine samples
Authors:
- 5 December 2011
- journal article
- research article
- Published by Wiley in Journal of Separation Science
- Vol. 35 (1) , 145-152
Abstract
In this paper, two methods based on organic solvent dispersive liquid–liquid microextraction (OS‐DLLME) and ionic liquid dispersive liquid–liquid microextraction (IL‐DLLME) coupled with high‐performance liquid chromatography have been critically compared for analyzing emodin and its metabolites (aloe‐emodin, anthraquinone‐2‐carboxylic acid, rhein, danthron, chrysophanol and physcion) in urine samples. Several important parameters influencing the extraction recoveries of DLLME were carefully optimized. Under optimal conditions, the enrichment factors (EFs) for emodin and its metabolites by OS‐DLLME and IL‐DLLME were within the range of 90–295 and 63–192 respectively; the relative standard deviations (RSDs, n=3) for intra‐day and inter‐day precision were lower than 7.2 and 8.7% by OS‐DLLME, and lower than 5.7 and 6.4% by IL‐DLLME; the recoveries of emodin and its metabolites were from 87.1 to 105% for OS‐DLLME and from 94.8 to 103% for IL‐DLLME, respectively. There were no significant deviations between the two methods for the determination of emodin and its metabolites. From the results of HPLC/UV of urine sample after DLLME, the metabolites aloe‐emodin, rhein, chrysophanol and physcion were identified by comparing the retention times with the standards. From the results of HPLC/MS, anthraquinone‐2‐carboxylic acid and danthron as unreported metabolites of emodin were found.Keywords
Funding Information
- National Nature Science Foundation of China (81041084)
- Nature Science Foundation of Shanxi Province, China (2011011035-2)
- Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province, China
- Innovation Foundation of Shanxi Medical University, China
This publication has 28 references indexed in Scilit:
- Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathwayEuropean Journal of Pharmacology, 2008
- Emodin, an anthraquinone derivative from Rheum officinale Baill, enhances cutaneous wound healing in ratsEuropean Journal of Pharmacology, 2007
- Electrochemical studies of the interaction of the anticancer herbal drug emodin with DNAJournal of Pharmaceutical and Biomedical Analysis, 2006
- Evaluation of the antibacterial activity ofVentilago madraspatana Gaertn.,Rubia cordifolia Linn. andLantana camara Linn.: isolation of emodin and physcion as active antibacterial agentsPhytotherapy Research, 2005
- Direct ab initio dynamics studies of the hydrogen abstraction reactions of hydrogen atom with n-propyl radical and isopropyl radicalJournal of Molecular Modeling, 2004
- Evaluation of the anti-inflammatory and cytotoxic effects of anthraquinones and anthracenes derivatives in human leucocytesJournal of Pharmacy and Pharmacology, 2004
- Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum OhwiInflammation Research, 2001
- Myocardial protection by Protykin, a novel extract oftrans-resveratrol and emodinFree Radical Research, 2000
- Immunosuppressive effect of emodin, a free radical generatorEuropean Journal of Pharmacology, 1992
- Vasorelaxant effect of emodin, an anthraquinone from a Chinese herbEuropean Journal of Pharmacology, 1991